Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 + Bevacizumab Maintenance in Advanced Colorectal Cancer
NCT06293014Phase 2Recruiting
- Sponsor
- Henan Cancer Hospital
- Start
- Feb 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in colorectal cancer (CRC), sponsored by Henan Cancer Hospital. Started Feb 2024; status: recruiting.
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06293014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06293014.